Will This Analyst Upgrade Help Envision Healthcare (EVHC) Stock Today?

NEW YORK (TheStreet) -- Goldman Sachs upgraded Envision Healthcare  (EVHC) to "buy" from "neutral," set a $43 price target and placed the stock on its Conviction List. The firm noted the company's outlook is improving and it trades at a compelling valuation.

The stock closed at $35.95 on Friday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EVHC Chart

EVHC data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

GM, Teva, Facebook and Other New Jana Partners Positions

GM, Teva, Facebook and Other New Jana Partners Positions

Jim Cramer: Looking for Treasure in the Cellar

Jim Cramer: Looking for Treasure in the Cellar

Don't Get Caught Out in the Cold: Cramer's 'Mad Money' Recap (Friday 1/5/18)

Don't Get Caught Out in the Cold: Cramer's 'Mad Money' Recap (Friday 1/5/18)

Cramer: Looking for Treasure in the Cellar

Cramer: Looking for Treasure in the Cellar

Hurricane Irma Now Category 4, Still Headed for Florida

Hurricane Irma Now Category 4, Still Headed for Florida